BioLife Solutions
BLFS
216 hedge funds and large institutions have $1.4B invested in BioLife Solutions in 2026 Q2 according to their latest regulatory filings, with 57 funds opening new positions, 84 increasing their positions, 53 reducing their positions, and 25 closing their positions.
300% more funds holding in top 10
Funds holding in top 10: 1 → 4 (+3)
128% more first-time investments, than exits
New positions opened: 57 | Existing positions closed: 25
58% more repeat investments, than reductions
Existing positions increased: 84 | Existing positions reduced: 53
52% more call options, than puts
Call options by funds: $2.52M | Put options by funds: $1.65M
47% more capital invested
Capital invested by funds: $952M → $1.4B (+$444M)
16% more funds holding
Funds holding: 187 → 216 (+29)
2.03% less ownership
Funds ownership: 103.28% → 101.25% (-2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$14.6M |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$13.2M |
| 3 |
RC
Roubaix Capital
Denver,
Colorado
|
+$7.24M |
| 4 |
BlackRock
New York
|
+$6.4M |
| 5 |
Goldman Sachs
New York
|
+$6.22M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CC
Casdin Capital
New York
|
-$30.4M |
| 2 |
Ameriprise
Minneapolis,
Minnesota
|
-$19.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$11.2M |
| 4 |
PCM
Palisade Capital Management
Fort Lee,
New Jersey
|
-$9.49M |
| 5 |
CRC
Curi RMB Capital
Chicago,
Illinois
|
-$8.13M |
BLFS Hedge Fund Activity: Q2 2026 in Review
216 of the 8,305 institutional investors tracked by Wall St. Rank reported a position in BioLife Solutions (BLFS) for Q2 2026, worth a combined $1.4B — up 47% from $952M a quarter earlier.
Buyers outnumbered sellers: 57 funds opened new BLFS positions and 25 closed out — a net gain of 32 holders — while 84 added to existing stakes and 53 trimmed.
The largest buyer was Millennium Management, opening a new position worth an estimated $14.6M. The largest seller was Casdin Capital, cutting an estimated $30.4M.
- 216 institutional investors held BioLife Solutions (BLFS) as of Q2 2026, up from 187 in Q1 2026.
- Funds reported $1.4B of BioLife Solutions stock for Q2 2026, up 47% quarter-over-quarter.
- 57 funds opened new BioLife Solutions positions in Q2 2026 and 25 closed out, a net change of +32 holders.
- The largest BioLife Solutions buyer in Q2 2026 was Millennium Management, an estimated $14.6M added.
- The largest BioLife Solutions seller in Q2 2026 was Casdin Capital, an estimated $30.4M sold.
Based on aggregated 13F filings for Q2 2026.